We have also shown that although CD8+ and Foxp3+ T-cells are concordant between primary and metastatic lesions, primary RCC is associated with a higher CD8+ TIL density and CD8:Foxp3 T-cell ratio, supporting the need to assess metastatic sites when treating distant disease. This evidence concerns the gene FOXP3 and renal cell carcinoma.